Category Archives: Genetics

Scientists discover genetic and immunologic underpinnings of some cases of severe COVID-19 – National Institutes of Health

Media Advisory

Thursday, September 24, 2020

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.

The researchers found that more than 10% of people who develop severe COVID-19 have misguided antibodiesautoantibodiesthat attack the immune system rather than the virus that causes the disease. Another 3.5% or more of people who develop severe COVID-19 carry a specific kind of genetic mutation that impacts immunity. Consequently, both groups lack effective immune responses that depend on type I interferon, a set of 17 proteins crucial for protecting cells and the body from viruses. Whether these proteins have been neutralized by autoantibodies orbecause of a faulty genewere produced in insufficient amounts or induced an inadequate antiviral response, their absence appears to be a commonality among a subgroup of people who suffer from life-threatening COVID-19 pneumonia.

These findings are the first published results from the COVID Human Genetic Effort, an international project spanning more than 50 genetic sequencing hubs and hundreds of hospitals. The effort is co-led by Helen Su, M.D., Ph.D., a senior investigator at the National Institute of Allergy and Infectious Diseases (NIAID), part of NIH; and Jean-Laurent Casanova, M.D., Ph.D., head of the St. Giles Laboratory of Human Genetics of Infectious Diseases at The Rockefeller University in New York. Major contributions were made by Luigi Notarangelo, M.D., chief of the NIAID Laboratory of Clinical Immunology and Microbiology (LCIM); Steven Holland, M.D., director of the NIAID Division of Intramural Research and senior investigator in the NIAID LCIM; clinicians and investigators in hospitals in the Italian cities of Brescia, Monza and Pavia, which were heavily hit by COVID-19; and researchers at the Uniformed Services University of the Health Sciences in Bethesda, Maryland.

The wide variation in the severity of disease caused by SARS-CoV-2, the virus behind COVID-19, has puzzled scientists and clinicians. SARS-CoV-2 can cause anything from a symptom-free infection to death, with many different outcomes in between. Since February 2020, Drs. Su and Casanova and their collaborators have enrolled thousands of COVID-19 patients to find out whether a genetic factor drives these disparate clinical outcomes.

The researchers discovered that among nearly 660 people with severe COVID-19, a significant number carried rare genetic variants in 13 genes known to be critical in the bodys defense against influenza virus, and more than 3.5% were completely missing a functioning gene. Further experiments showed that immune cells from those 3.5% did not produce any detectable type I interferons in response to SARS-CoV-2.

Examining nearly 1,000 patients with life-threatening COVID-19 pneumonia, the researchers also found that more than 10% had autoantibodies against interferons at the onset of their infection, and 95% of those patients were men. Biochemical experiments confirmed that the autoantibodies block the activity of interferon type I.

Q Zhang et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science DOI: 10.1126/science.abd4570 (2020).

P Bastard et al. Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. Science DOI: 10.1126/science.abd4585 (2020).

NIAID Director Anthony S. Fauci, M.D., NIAID Senior Investigator Helen C. Su, M.D., Ph.D., and Luigi Notarangelo, M.D., chief of the NIAID Laboratory of Clinical Immunology and Microbiology, are available for interviews.

To schedule interviews, please contact NIAID Office of Communications, (301) 402-1663, NIAIDNews@niaid.nih.gov.

NIAID conducts and supports research at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

Link:
Scientists discover genetic and immunologic underpinnings of some cases of severe COVID-19 - National Institutes of Health

Zelis and Concert Genetics Launch Genetic Testing Claim Editing Solution – Business Wire

BEDMINSTER, N.J. & NASHVILLE, Tenn.--(BUSINESS WIRE)--Zelis, the healthcare industrys leading claims cost and payments optimization platform with superior technology and solutions to price, pay and explain claims, and Concert Genetics, a technology company dedicated to advancing precision medicine, have launched a claim editing solution for the complex and rapidly-growing area of genetic testing.

The solution embeds Concerts claim editing capabilities, which are powered by robust genetic testing market data and machine learning, into Zelis existing claim editing platform. This leading-edge platform already contains more than 18 million edits sourced to national coding standards. The partnership adds specialized content in genetic testing that other platforms lack, enabling Zelis and Concert to improve coding and billing accuracy of these complex and ambiguous genetic test claims before they are paid.

Our clients are experiencing higher costs due to the complexity of managing the variability of genetic testing codes and volume of new tests entering the market, said R. Andrew Eckert, Zelis CEO. Combining our payment integrity expertise with Concerts precision technology will enable us to proactively identify inaccurate claims and continue to support our clients with innovative solutions to reduce costs.

This solution comes at a critical time, as the availability and demand for genetic tests grow with the global genetic testing market expected to reach $17.6 billion by 2025, from $7.5 billion in 2017.1 Additionally, the total number of available genetic testing products has surpassed 150,000, up from around 10,000 in 2012. Meanwhile, much of the growth in volume is represented by multi-gene panel tests, which are particularly difficult for health plans to process in an efficient and accurate way because they are billed using multiple billing codes in widely varying combinations. Some categories of genetic tests are billed in thousands of different code combinations.

The pace of advancement in the science and clinical application of genetics is remarkable, and the healthcare system has had difficulty keeping up, said Rob Metcalf, CEO of Concert Genetics. Concert has assembled the data and digital infrastructure to enable transparency, connectivity, and value in this space, and we are pleased to partner with Zelis to make our technology available to its clients.

A key enabler of this claim editing solution is its ability to match complex claims with multiple billing codes back to its catalog of tests on the market. The combined solution is available to Zelis clients effective immediately.

About Zelis

Zelis is the healthcare industrys leading claims cost and payments optimization platform with superior technology and solutions to price claims, pay claims and explain claims, all at enterprise scale on a claim-by-claim basis. Zelis leverages proprietary technology, robust analytics, extensive payment and provider networks, and innovative claim savings channels to deliver to the industry superior administrative and medical cost savings. Zelis was founded on a belief that there is a better way to determine the cost of a healthcare claim, manage payment related data, and make the claim payment. Zelis provides the industrys only comprehensive, integrated platform to take a claim through the entire pre-payment to payments lifecycle. Zelis ~1000 associates serve more than 700 payor clients, including the top-5 national health plans, Blues plans, regional health plans, TPAs and self-insured employers, and more than 1.5 million providers. Zelis delivers more than $5B of claims savings, $50B of provider payments and 500 million payment data communications annually.

About Concert Genetics

Concert Genetics is a software and managed services company that advances precision medicine by providing the digital infrastructure for reliable and efficient management of genetic testing. Concerts market-leading genetic test order management platform leverages a proprietary database of the U.S. clinical genetic testing market today more than 150,000 testing products and genetic testing claims from more than 100 million lives. Learn more at http://www.ConcertGenetics.com.

1 Allied Market Research report, Genetic Testing Market by Type (Predictive Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, and Others), Technology (Cytogenetic Testing, Biochemical Testing, and Molecular Testing), and Application (Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, and Others): Global Opportunity Analysis and Industry Forecast, 20182025

Go here to read the rest:
Zelis and Concert Genetics Launch Genetic Testing Claim Editing Solution - Business Wire

NIH researchers find genetic link in patients with severe COVID-19 – fox6now.com

United launches rapid COVID-19 testing program for some travelers

United Airlines plans to offer COVID-19 tests for passengers flying from San Francisco International Airport to Hawaii.

LOS ANGELES - Scientists at the National Institutes of Health (NIH) say they have found how genetics play a critical role in who develops severe cases of COVID-19 and why more men than women die from the illness.

Much is still being learned about the novel coronavirus that has claimed the lives of more than 200,000 people in the U.S. Nearly 1 million deaths have been recorded worldwide to date, according to data tracked by Johns Hopkins University.

Researchers have rushed to study the unpredictable and wide variations in illness severity that the virus causes in different people. Determining whether a genetic factor contributes to the virus severity and health outcomes of COVID-19 patients is highly important for researchers to develop a solution to the crisis.

Results published as part of the COVID Human Genetic Effort, an international project consisting of more than 50 genetic sequencing hubs and hundreds of hospitals, found that more than 10% of people who develop a severe case of the coronavirus have misguided antibodies which attack the immune system.

FILE - A medical laboratory scientist runs a clinical test in the Immunology lab at UW Medicine looking for antibodies against SARS-CoV-2. (Photo by Karen Ducey/Getty Images)

Researchers found that another 3.5% of people who develop severe COVID-19 carry a specific genetic mutation which negatively impacts immunity from the disease.

Consequently, both groups lack effective immune responses that depend on type I interferon, a set of 17 proteins crucial for protecting cells and the body from viruses," according to a news release by the NIH.

The researchers discovered that among nearly 660 people with severe COVID-19, a significant number carried rare genetic variants in 13 genes known to be critical in the bodys defense against influenza virus, and more than 3.5% were completely missing a functioning gene, the NIH wrote.

The health agency said the absence of these proteins appear to be common among a subgroup of people who are at risk of life-threatening effects of COVID-19.

After examining 1,000 patients with life-threatening pneumonia caused by the coronavirus, researchers found that 10% of patients had the misguided antibodies, otherwise known as autoantibodies, which defended against the interferon proteins needed to protect the cells. Of those patients with harmful antibodies, 95% were men.

RELATED: Could your symptoms be COVID-19? The signs range from mild to severe

Health officials say that becoming infected with COVID-19 can lead to a wide variety of symptoms, ranging from mild to severe. The most common symptoms are fever, a dry cough, shortness of breath and fatigue.

But as the months-old virus continues its spread, additional symptoms are being identified and they can be unpredictable.

The U.S. Centers for Disease Control and Prevention highlights 11 key symptoms of COVID-19 on its website:

Fever or chillsCoughShortness of breath or difficulty breathingFatigueMuscle or body achesHeadacheNew loss of taste or smellSore throatCongestion or runny noseNausea or vomitingDiarrhea

The agency notes that the list does not include all possible symptoms of COVID-19, and said that it would continue to update the list as more becomes known about the virus.

Kelly Taylor Hayes contributed to this story.

Original post:
NIH researchers find genetic link in patients with severe COVID-19 - fox6now.com

Researchers elucidate the impact of genetic mutations in cocaine addiction – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Sep 26 2020

Cocaine addiction is a chronic disorder with a high rate of relapse for which no effective treatment is currently available.

Scientists from the Institut Pasteur, the CNRS, Inserm and the Paris Public Hospital Network (AP-HP) recently demonstrated that two gene mutations involved in the conformation of nicotinic receptors in the brain appear to play a role in various aspects of cocaine addiction. The results of the study were published in Progress in Neurobiology.

There are approximately 18 million users worldwide, and cocaine is implicated in more than 50% of overdose deaths in the United States and 25% in France. It is also one of the only drugs for which there is no approved pharmacological treatment.

Cocaine acts primarily in the brain by blocking the dopamine transporter, thereby increasing the concentration of this "pleasure" molecule in the reward system. But cocaine can also act directly on the nicotinic receptors1 in the brain.

Several human genetics studies have recently suggested that a mutation in the gene encoding the 5 subunit of nicotinic receptors, hereafter referred to as '5SNP', already known to increase the risk of tobacco dependence,2 may conversely also confer "protection" against cocaine addiction.

This mutation is highly present in the general population (approximately 37% of Europeans and up to 43% of the Middle Eastern population carry it), so it is important to determine how it affects cocaine addiction and, more generally, to better understand the role of the 5 nicotinic subunit in the effects of cocaine.

Scientists of the Integrative Neurobiology of Cholinergic Systems Unit (Institut Pasteur/CNRS) began by evaluating the role of the 5 nicotinic subunit and the impact of the 5SNP mutation on various processes involved in the development of cocaine addiction in animal models. The results obtained were then used to characterize more specifically its impact on humans.

The scientists observed that the 5SNP mutation reduces the voluntary intake of cocaine upon first exposures.

These preclinical data suggest that the mutation protects against cocaine addiction by modulating an early phase in the addiction cycle."

Morgane Besson, Study Lead Author, Institut Pasteur

Working in collaboration with the Paris Public Hospital Network (AP-HP) and Inserm, the scientists then confirmed this significant effect in approximately 350 patients with cocaine addiction: those with the mutation exhibited a slower transition from first cocaine use to the emergence of signs of addiction.

At the same time, the authors showed that a total absence of the 5 nicotinic subunit increased the risk of relapse after withdrawal in preclinical models. This led the scientists to identify another mutation in another nicotinic subunit, 4, associated with a shorter time to relapse after withdrawal in addicted patients.

Taken together, these results elucidate the role played by both a highly frequent mutation in the 5 nicotinic subunit and the subunit itself in various stages of cocaine addiction. The research suggests that drugs modulating nicotinic receptors containing this 5 subunit could represent a novel therapeutic strategy for cocaine addiction.

Source:

Journal reference:

Forget, B., et al. (2020) Alterations in nicotinic receptor alpha5 subunit gene differentially impact early and later stages of cocaine addiction: a translational study in transgenic rats and patients. Progress in Neurobiology. doi.org/10.1016/j.pneurobio.2020.101898.

See more here:
Researchers elucidate the impact of genetic mutations in cocaine addiction - News-Medical.Net

Capturing marine biodiversity with the power of genetics – Australian Antarctic Division

Scientists at the Australian Antarctic Division are studying small drops of the enormous Southern Ocean to find out which animals live within it using new genetic methods.

The ocean encircling an entire continent and joining the worlds oceans supports a polar food web that is globally unique and teeming with life.

Ongoing monitoring of Southern Ocean biodiversity will be crucial for scientists to assess the impact of a rapidly changing climate on the marine ecosystem.

Its hugely important to actually monitor how things are changing, said AAD genetics researcher Dr Leonie Suter. Its a pretty big deal.

How best to capture that information has been the subject of a two-year research project, detailed in the journal of Molecular Ecology.

The Continuous Plankton Recorder (CPR) has been capturing snapshots of the ocean for the last century.

Its a device dropped into the water and towed behind a ship at a constant speed on a narrow path, for 450 nautical miles at a time.

It works by trapping plankton between fine sheets of silk, the contents of which is examined back in the laboratory by taxonomists who microscopically identify, log and analyse whole organisms.

CPR surveys have been run by the Australian Antarctic Program across vast swathes of the Southern Ocean since 1991, involving ships from several nations.

A staggering amount of data has been amassed around 47,000 samples analysed from more than 1000 CPR tows for a total of approximately 240,000 nautical miles.

Now a new method harnessing the power of genetic sequencing, called environmental DNA metabarcoding, promises to extend our information about biodiversity.

If DNA is like a biochemical barcode unique to every species, eDNA metabarcoding records the traces of those organisms left in their surroundings.

Environmental DNA is pretty much the DNA that is shed by any organism into the environment, said Dr Leonie Suter.

So in the marine environment, imagine a fish shedding a scale or doing a poo, or spawning, or dying and slowly decaying.

With genetic methods, we can extract this DNA from quite small water samples and from that determine what actually lives in the environment.

Unlike conventional methods, analysing eDNA doesnt require an entire organism to establish a snapshot of whats in the water.

The team analysed water samples taken from the Southern Ocean between Tasmania and Macquarie Island.

For comparable results, where 1500 litres of seawater was filtered through the Continuous Plankton Recorder over five nautical miles, the eDNA method relied on just two litres taken at a single location, piped cleanly and directly from the ocean onto the Aurora Australis research vessel.

All youre really doing is turning a tap and in your lab collecting two litres of water that you can filter on site. This filter is then used for genetic analysis, said Dr Suter.

So you dont need to even go on the deck of the ship or anything, youre in a quite safe environment. You turn your tap and collect your sample to find out what lives in the ocean, which is quite amazing.

Dr Suter said this eDNA metabarcoding method is a relatively new concept in the Southern Ocean.

The open ocean is quite different to other environments. The water body is just so big, she said.

It all dilutes quite quickly, there are currents and other factors that spread the eDNA out quite quickly. So we werent sure how well this would work.

When eDNA and CPR samples were both processed genetically, eDNA detected about two thirds of the species that were detected with CPR.

This is quite amazing considering the difference in sampled water volume. Both methods detected similar species that contributed to community differentiation across different environments, said Dr Suter.

When eDNA metabarcoding was compared to morphological analyses (whole organisms) of CPR samples, eDNA detected up to 1.5 times more species.

The overlap of species detected with the two methods was small, suggesting that eDNA is more of a complementary method to traditional CPRs.

Because the open ocean is prone to quickly degrading the quality of minute eDNA samples, multiple eDNA samples at different times of the day should be collected to establish a more complete picture.

Dr Suter said more refining of sampling and processing could lead to an unprecedented biodiversity monitoring capacity in the open ocean for future research.

Its personally a really big achievement for me because Ive got three little kids at home, said Dr Suter, also the lead author.

I started working on this when my twins were four months old. So its been pretty big for me to achieve this work. And obviously its not just my work. Its a big team effort.

Im really proud that we managed to get it out.

In addition, the team is now developing targeted Antarctic krill markers to test how abundant the species is in the Southern Ocean and inform the future management of the krill fishery.

The AADs new icebreaker RSV Nuyina will also be equipped for ongoing monitoring of eDNA.

Whenever the ship goes out we hope to be collecting water samples to analyse and start creating a long-term monitoring program, said Dr Suter.

This content was last updated 2 days ago on 25 September 2020.

Read more:
Capturing marine biodiversity with the power of genetics - Australian Antarctic Division

ADHD is partially genetic, but there are other risk factors that play a key role – Insider – INSIDER

Some mental health conditions have genetic components, and the same can be said for attention deficit hyperactivity disorder (ADHD).

Research have some insight into the genetic component of the condition. However, there are more to potential causes of ADHD aside from just your genes.

Here's what scientists know so far about the heritability of ADHD and how it compares to other risks that contribute to the condition.

Though it's unclear how significant a role genetics plays, studies have shown that having a parent or sibling can drastically increase one's risk of developing ADHD.

For example, a 2016 study published in Neuropsychiatric Disease and Treatment found that in the sample of 79 children with ADHD, 41.3% had mothers with ADHD and 51% had fathers with ADHD.

Another study, published in 2017 in Revista Colombiana de Psiquiatra, found that siblings of someone with ADHD had a 26% to 45.2% chance of also having ADHD making it a greater likelihood than if no siblings had ADHD.

Another 2014 studyof 59,514 twins found the heritability of ADHD the likelihood of a genetic component for the condition to be 88%. However, genetics are likely not the sole factor for whether or not a person develops ADHD.

"Since siblings also share a social, physical, and rearing environment, this in itself does not prove genetic rather than potentially shared environmental causes," says Robert King, MD,

Pediatric Developmental and Behavioral Medicine Psychiatrist and Medical Director of the Tourette's/OCD Clinic at Yale Child Study Center.

There is no one gene that causes ADHD, and there is no test you can take to determine your risk of developing it. In fact, ADHD is most likely a condition associated with multiple genes, not just one, says King.

But researchers have hypothesized that one gene in particular, the DRD4 gene, may play a part in ADHD. The DRD4 gene affects dopamine receptors in the brain, which in turn can influence brain function and mental disorders associated with brian function, including ADHD. However, how strong a role DRD4 plays in ADHD, specifically, remains unclear.

King says that researchers have found other rare genes that are associated with different aspects of brain development, but clarifies that "although these are of interest in suggesting new research leads, they are found only in a very small number of cases of ADHD and are not useful as any sort of diagnostic test."

Another factor that makes genetic studies for ADHD so complicated is the fact that ADHD is often co-occurring with other mental health conditions like anxiety, depression, and tic disorders, King says, and these disorders may also be partly genetic.

King says that aside from genetics, various other factors predispose somebody to ADHD, and some of them are preventable. Some examples of ADHD risk factors are:

While genetics are not the only factor in whether or not someone develops ADHD, there certainly is a genetic component, which has been proven through years of scientific research. However, there is not one specific gene that is directly associated with ADHD.

There are multiple non-genetic risk factors that may contribute to an individual's ADHD, as well. Regardless of what caused somebody's ADHD, there are multiple treatment options available that can help manage ADHD symptoms and improve quality of life.

Go here to see the original:
ADHD is partially genetic, but there are other risk factors that play a key role - Insider - INSIDER

Genetic variation not linked with differences in COVID-19 morbidity and mortality – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Sep 24 2020

A comprehensive search of genetic variation databases has revealed no significant differences across populations and ethnic groups in seven genes associated with viral entry of SARS-CoV-2.

African Americans and Latinos in the United States and ethnic minorities in the United Kingdom are disproportionately affected by COVID-19. They are more likely to develop severe symptoms and also show significantly higher mortality compared with other regional and ethnic groups.

To investigate if this disparity could be caused by genetic variation, a team of three researchers - including Assistant Professor Ji-Won Lee of Hokkaido University's Graduate School of Dental Medicine - surveyed publicly available databases of genomic variants, including gnomAD, the Korean Reference Genome Database, TogoVar (a Japanese genetic variation database) and the 1000 Genomes Project. They studied variants across multiple regional and ethnic groups in seven genes known to play roles in viral entry into host cells and recognition of viral RNA in host cells.

SARS-CoV-2 has spiked protein (S protein) on its envelope, which encloses the virus. Before the virus can enter host cells, the S protein has to bind with the ACE2 receptor on the cell surface. It is then broken into two pieces by the enzymes TMPRSS2 and cathepsin B and L. After the virus enters the cells, the viral RNA binds with proteins such as TLR3, TLR7 and TLR8, triggering an innate immune response.

According to the results, there were genetic variants in these seven proteins, with the largest number of variants in ACE2. However, very few of these variations alter the functions of these proteins. Since the overall variation frequency was extremely low (less than 0.01 percent), the scientists determined there is no significant difference across populations or ethnic groups in the functions of the seven proteins involved in infection.

The team's findings suggest that differences in morbidity and mortality are not the result of genetic variations in genes for viral entry across populations. Rather, it is more likely that preexisting medical conditions, individual medical histories, environmental factors and healthcare disparities play a significant role in affecting the morbidity and mortality of COVID-19. However, due to the limited size of the population databases used in this study, additional research using more diverse human genome databases is required. Additionally, other studies have shown that genetic factors may contribute to serious cases.

Also taking part in the study were In-Hee Lee of Boston Children's Hospital (Computational Health Informatics Program) and Sek Won Kong of Harvard Medical School (Department of Pediatrics). The team's findings were published online on August 25, 2020, in the medical journal Infection, Genetics and Evolution.

Source:

Journal reference:

Lee, I., et al. (2020) A survey of genetic variants in SARS-CoV-2 interacting domains of ACE2, TMPRSS2 and TLR3/7/8 across populations. Infection, Genetics and Evolution. doi.org/10.1016/j.meegid.2020.104507.

Excerpt from:
Genetic variation not linked with differences in COVID-19 morbidity and mortality - News-Medical.Net

Many functionally connected loci foster adaptive diversification along a neotropical hybrid zone – Science Advances

Abstract

Characterizing the genetic complexity of adaptation and trait evolution is a major emphasis of evolutionary biology and genetics. Incongruent findings from genetic studies have resulted in conceptual models ranging from a few large-effect loci to massively polygenic architectures. Here, we combine chromatin immunoprecipitation sequencing, Hi-C, RNA sequencing, and 40 whole-genome sequences from Heliconius butterflies to show that red color pattern diversification occurred via many genomic loci. We find that the red wing pattern master regulatory transcription factor Optix binds dozens of loci also under selection, which frequently form three-dimensional adaptive hubs with selection acting on multiple physically interacting genes. Many Optix-bound genes under selection are tied to pigmentation and wing development, and these loci collectively maintain separation between adaptive red color pattern phenotypes in natural populations. We propose a model of trait evolution where functional connections between loci may resolve much of the disparity between large-effect and polygenic evolutionary models.

Identifying the genetic basis of both the origin and maintenance of adaptive traits is essential for the study of diversification. Recent studies disagree, however, on the complexity of adaptive trait architecture, largely because approaches used for genetic mapping are often inconsistent. Quantitative trait loci (QTL) studies investigating the genetic basis of adaptive traits have repeatedly mapped natural variation to a few Mendelian loci (1, 2). Similarly, studies of the loci differentiating adaptive phenotypes in hybrid zones frequently find a handful of genes that strongly segregate by phenotype (35). Yet, these observations are increasingly incongruent with genome-wide association studies (GWAS), selection associated with trait variation, and studies incorporating artificial selection, which all regularly find many natural genetic variants of differing effect sizes that associate with trait variation (68). This has led to several proposals that many traits may be highly or massively polygenic (9, 10). An oligogenic or polygenic architecture would, in turn, suggest that a larger subset of causal variants might also contribute to maintaining adaptive traits between hybridizing taxa. The discrepancy between QTL studies, known for bias toward a few loci of large effect, and the often multigenic composition of natural trait-associated variation is not new, yet reconciliation of these disparate findings has been a challenge (9).

Here, we study hybridizing populations of Heliconius erato butterflies as a natural model for resolving this conflict. In Ecuador and Peru, evolutionarily derived Radiate morphs of H. erato form hybrid zones along the Andes with several Postman morphs (Fig. 1A) (5). In this region, genome-wide divergence is low, effective population sizes are high (11), gene flow is frequent between hybridizing morphs (12), and populations are only strongly differentiated by three known color patternassociated loci around WntA, cortex, and optix (Fig. 1B). The master regulator gene optix acts as a classic Mendelian gene of large effect, and both QTL studies and scans for genomic differentiation in hybrid zones have mapped control of adaptive red mimicry color pattern variation to optix (3, 1316). Recent study of the Radiate phenotype in H. erato found that wing patterns evolved via selection on at least five pleiotropic cis-regulatory loci and that these elements were shared by all Radiate morphs through adaptive introgression (17). Yet, despite the singular importance of optix for red wing pattern evolution, studies in Heliconius have found that quantitative variation in red wing patterns maps to at least 15 of the 21 chromosomes in Heliconius (shown in Fig. 1C), indicating that many more loci may be important contributors to red color pattern adaptation in the genus (1821). In this study, we investigate the population genetic signatures of additional loci associated with adaptive diversification and assess the extent to which these may be functionally connected to optix.

(A) Postman (western) and Radiate (eastern) metapopulations show Andean hybrid zone between morphs. (B) Genomic differentiation between Radiate and Postman metapopulations with three major color pattern loci annotated. (C) Signatures of selective sweeps in the Radiate metapopulation shows many loci under selection. Bars mark chromosomes significantly associated with red pattern variation in H. melpomene (red) and H. erato (orange).

We predicted that additional loci in the optix gene network may have contributed to the adaptive diversification of the Radiate morphology. Because Optix is a transcription factor that binds cis-regulatory elements (CREs; fig. S1A), focusing on Optix-bound loci limited our analysis to genes directly regulated by the master regulator of red wing coloration in butterflies. To test for additional adaptive evolution causally linked to red color pattern variation in H. erato, we intersected a whole genome scan for selective sweeps using SweepFinder2 (22) in a metapopulation of Radiate morphs (Fig. 1C) with downstream targets of the Optix protein in midpupal wing tissue. Consistent with the hypothesis that much of the Optix-associated gene network may be under selection, Optix-bound CREs showed significantly greater evidence of selective sweeps than expected from CREs drawn randomly from wing assay for transposase-accessible chromatin sequencing (ATAC-seq) data at the same developmental stage (Fig. 2A). The composite likelihood ratio produced by SweepFinder2 is capable of detecting hard sweeps (22), introgressed sweeps (23), and, to a lesser extent, soft sweeps [e.g., (24)]. Thus, much of the enriched composite likelihood ratio (CLR) signal observed at Optix-bound CREs is likely due to selection on alleles with varying origins and evolutionary histories, and some additional soft sweeps may be identified in future studies.

(A) Optix binding sites show significantly greater signatures of selective sweeps than expected from annotated CREs chosen randomly from the same developmental stage. The 99.5th percentile line shows the cutoff threshold for strong signals of selection, and bracket highlights the number of Optix-bound and control loci above this threshold. (B) Optix-bound loci with strong signals of selection often form three-dimensional (3D) adaptive hubs. (C) Adaptive hub transcriptional start sites (TSSs) show elevated selection compared to other regulatory elements. (D) Functional characterization of known genes at loci with strong signals of selection and adaptive hubs are often pigment associated.

We next used physical, Hi-Cbased evidence of CRE-to-gene interactions to link Optix binding sites to gene promoters and selected CREs intersecting with selective sweep values (CLR) in the top 0.5% of all CLR scores as loci displaying strong signals of positive selection (fig. S1, B and C). Fifty-nine loci met the criteria of Optix binding and high CLR values and were designated as additional loci of putative adaptive evolution driven by changing optix expression domains (Fig. 2B). Targets of the Optix protein displaying a strong signal of selection were found on 15 of 21 chromosomes, including all but two chromosomes implicated in red color pattern variation (Fig. 1C and fig. S2A) (1821). Together, evidence of increased selection on Optix binding sites and numerous loci with strong signals of selection in the Radiate metapopulation provide compelling support for a multigenic adaptive process such as the two-step model proposed by Sheppard et al. (13) and Baxter et al. (20).

Our finding that Optix binding sites are generally under increased selection pressure led us to investigate the three-dimensional landscape of adaptation at loci with strong signatures of selection. To accomplish this, we compared our results to RNA sequencing (RNA-seq) assays of differential gene expression between wing tissue of Radiate and Postman butterflies at the same developmental stage (25). We found that 65% of Optix binding sites that display strong signals of selection formed cis-acting adaptive hubs, characterized by a single CRE in the top 0.5% of CLR values that physically connects with two or more genes that are differentially expressed between Radiate and Postman butterflies (Fig. 2C). Adaptive hubs are defined locally by the presence of an Optix binding site with a strong signal of selection in the Radiate metapopulation, with Hi-C evidence of physical loops to at least two additional transcriptional start sites (TSS) of genes differentially expressed between wing pattern morphs. Thus, adaptive hubs are cis-acting networks of genes in close physical proximity that are regulated by Optix and associated with color pattern variation between morphs. This differs from developmental hubs derived from statistical analysis of network connectivity that focus primarily on identifying large-scale genetic interaction networks with both cis and trans interactions [e.g., (26, 27)]. Adaptive hub genes, excluding the hub center with a strong signal of selection, displayed significantly greater signatures of selection than expected when compared to both all genomic loci tested (all CLR values) and selection at all annotated gene TSSs (Fig. 2D). The median CLR value of hub genes indicated a moderate degree of selection and was greater than the 95th percentile of either control dataset. Consistent with our previous results showing increased selection on Optix-bound loci, two-thirds of adaptive hub genes were also bound by Optix, suggesting that selection can favor specific three-dimensional Optix-associated landscapes in addition to individual gene alleles.

We next annotated the function of known genes at adaptive hubs and loci with strong signatures of selection to determine the composition of putative adaptive loci. In total, 160 genes with known functions were linked to strong signals of selection on the Radiate optix expression domain, as determined by selection on Optix-bound TSSs or selection on distal CREs looping to the relevant TSS. Of these, 25% (39) had annotated pigmentation or wing patternassociated gene functions, including some well-characterized pigmentation genes, while an additional 8% (13) of genes performed a role in important signaling pathways such as the Toll or Dpp pathways (Fig. 2D and fig. S2B). Incorporation of pigmentation, patterning, and signaling genes with genes of other, less obvious functions points to a complex adaptive process targeting wing colorpatterning genes, biochemical processes, and potentially even compensatory mutations to account for maladaptive effects of the changing optix expression pattern.

Multiple lines of evidence implicate numerous loci in the adaptive diversification of the Radiate morph. However, the extent to which multiple loci also assist in maintaining adaptive divergence in the Radiate metapopulation remains unclear. Current models of diversification within H. erato suggest that the Radiate phenotype evolved in the western Amazon region about 300,000 years ago and became the model for several comimetic species in the Heliconius and Eueides genera (17, 28). Yet, despite strong ecological selection favoring the Radiate morphology, extensive hybridization with non-Radiate morphs of H. erato occurs along the Andes (3). The strongest signature of genomic differentiation between hybridizing red color pattern morphs occurs around optix, and this remains true with a fixation index (Fst) of 0.66 when comparing the Radiate metapopulation data to 22 whole-genome datasets from the Postman-like metapopulation along the western side of the Andes (Fig. 1B). Examination of loci with strong signals of selection also bound by Optix, however, makes it clear that many of these regions also act as a significant engine of genomic differentiation between metapopulations.

As a case study, we looked more closely at the Optix-bound promoter of the cotranscribed domeless/washout (dome/wash) genes, which is 500 kb away from the major color-patterning gene cortex and displays the strongest signature of selection within the Radiate metapopulation (Fig. 3A). The Optix-bound dome/wash promoter was not classified as an adaptive hub, indicating that while many loci associated with selection on Optix binding sites form adaptive hubs, strong candidate loci for color patternassociated divergence are not limited to hub loci. dome has been previously implicated in multiple butterfly wing patterning roles, including yellow mimicry patterns in Heliconius (29, 30). Specifically, the study of the presence or absence of a yellow hindwing bar phenotype in H. melpomene found a significant association between single-nucleotide polymorphisms (SNPs) at the dome/wash locus and the yellow bar pattern. In crosses of Peruvian H. melpomene Radiate and Postman morph butterflies, homozygotes for the yellow hindwing bar allele were dominant over the Radiate hindwing phenotype. In H. erato, this relationship was more complicated and dependent on alleles at multiple Mendelian loci (31). Evidence of Optix binding at the dome/wash promoter and prior association with mimicry phenotypes thus suggests that optix interacts epistatically with dome/wash, although additional study of this locus will be necessary to confirm this function.

The dome/wash color-patterning locus exemplifies a strong signal of selection (A) on an Optix binding site that displays elevated population differentiation (B) and population divergence (C). Loci with strong signals of selection (selected loci) and the pigment-associated subset show increasingly significant population differentiation (D) and divergence (E) between Radiate and Postman metapopulations relative to the genome-wide distributions.

A sliding window scan of Fst, which measures within- versus between-population differentiation, showed a high degree of differentiation at the cortex locus as expected, and that differentiation decreases with distance. Fst between the Radiate and Postman metapopulations elevates again around dome/wash, with differentiation well above the 99th percentile (Fig. 3B). While selection will often lower nucleotide diversity, which, in turn, reduces the average pairwise genomic divergence between neighboring populations [e.g., (32)], any accumulated SNPs should differ between metapopulations at loci that maintain genomic separation across hybrid zones (see Supplementary Text). Therefore, we next sought to determine the extent to which the available nucleotide polymorphisms drove divergence between the Radiate and Postman metapopulations independent of within-population diversity (33). To accomplish this, we measured the nucleotide divergence between the Radiate and Postman metapopulations, normalized to the available nucleotide diversity (dxy/pi; Fig. 3C). Confirming our Fst-derived observation implicating dome/wash as a locus separating metapopulations, dxy/pi was extremely elevated (99.99th percentile) with no evidence of haplotype exchange between the metapopulations.

To investigate the genome-wide significance of this observation, we extended our analysis of metapopulation differentiation to all Optix-bound loci with strong signals of selection. Fst values were significantly greater (P < 0.001) at putative adaptive loci compared to the genome-wide distribution, with the median value in the 93rd percentile and an upper bound of 0.083 (Fig. 3D and fig. S3). dxy/pi was also strongly elevated (P < 0.001) and showed an even greater increase over the genome-wide distribution (with a median in the 97th percentile) than the relative measure of genomic differentiation (Fig. 3E). Consistent with these loci separating metapopulations, rather than solely reflecting selection, neither Fst nor dxy/pi was strongly dependent on CLR at loci with strong signatures of selection (fig. S4). Together, our results clearly demonstrate that downstream targets of Optix regulation under recent positive selection also act as moderate to strong barriers to gene flow between hybridizing morphs.

Updating the previous hypothesis for red color pattern evolution in Heliconius (34), our results now suggest a two-component model of adaptive diversification that captures the distinct processes that underlie the evolution and maintenance of red mimicry color patterns in the Radiate H. erato metapopulation: First, multigenic adaptation occurs via selection on optix, a gene with complete developmental control of red pigmentation in butterflies, and many additional loci directly regulated by changing optix expression domains (Fig. 4A). The genes associated with adaptive evolution of the Radiate morphology indicate selection on pigment composition (e.g., black and UCH), wing morphology and patterning (nkd and osa), and apparent epistatic interactions with other color pattern networks (dome/wash and Wnt signaling). In the Radiate metapopulation, selection will be a product of the relative frequency of a variant (e.g., a novel mutation versus standing genetic variation), the effect size of selected variants, and the ecological significance of the resulting phenotype. Given the very large effective population size of most Heliconius species, selection can easily act on relatively weak-effect variants to optimize even seemingly minor aspects of the Radiate morphology. While our data-driven approach cannot identify all genes associated with red color pattern evolution, we nonetheless found considerable evidence that adaptation relies on many genes in the optix network.

(A) Model showing adaptation occurs at many loci, and selection is a product of population size, the effect of a mutation, and the significance of the trait. (B) Genomic differentiation in hybrid zones is determined by both selection and the probability that a conditionally dependent allele will be functional in backcrosses. (C and D) Cartoons show phenotypes and genotypes for hybrid and pure butterflies, and potential backcross offspring broods under two scenarios of differentiation. Direct differentiation (C) of a dominant allele occurs when a hybrid individual backcrosses into the source population. Any offspring with the maladaptive allele from the hybrid parent is less fit. In conditional differentiation (D), offspring with the maladaptive dependent allele are only less fit when that individual also has the maladapted optix allele.

The Radiate phenotype is then maintained by varying degrees of genomic isolation from the Postman metapopulation (Fig. 4B) at many loci through both direct and conditional (i.e., dependent on trans-allelic effects) differentiation at loci under selection (Fig. 4, C and D). Along the Andean hybrid zone between the Radiate and Postman metapopulations, genomic differentiation begins when a hybrid individual (F1 generation) backcrosses with one of the two source populations (F0 genotypes). The backcross produces maladapted offspring subject to selection in the Radiate metapopulation if the F1 Postman color pattern alleles are transferred to the F2 offspring. Allowing for recombination to narrow maladaptive haplotypes, this results in a relatively small region that fails to pass through the hybrid zone. Similar to selection on beneficial variants, the strength of differentiation is determined by the degree of selection on the resulting phenotype but also by the likelihood of a functional allele. In the case of optix, which is functionally independent of developmentally downstream variants, 50% of F2 offspring will have the maladaptive optix allele (18, 31, 35) and strong, direct differentiation occurs (Fig. 4C).

Our results suggest, however, that conditional differentiation is also prevalent in the Radiate metapopulation along the hybrid zone. Adaptive alleles that are regulated by and functionally dependent on optix will continue to segregate at a roughly 50:50 ratio. But because these loci mostly appear on other chromosomes, maladaptive Optix-dependent haplotypes will only appear (and be subject to selection) alongside a maladaptive optix allele in 25% of F2 offspring (Fig. 4D). Genomic differentiation at Optix-dependent loci is thus conditional on allelic variation at optix itself, when in the presence of a maladaptive optix haplotype, additional downstream genetic variants from the adjacent morph will also be maladaptive. For example, genetic variants relying on Optix activation in the hindwing will have no effect in individuals without the hindwing optix expression domain. The conditional effect on differentiation is compounded in cases where dependent variants may also interact, such as implied by the synergistic effect of HDAC4 and lesswright mutant alleles on Drosophila eye pigmentation (36). Since the degree of genomic differentiation at a locus is a function of the strength of selection and likelihood of a functional allele, the combination of selection and independent segregation of alleles can produce a wide range of differentiation at adaptive loci causally linked to optix expression. This can nonetheless be a strong force for maintaining genomic separation between phenotypes.

Our current data provide some additional findings consistent with the expectations of our adaptive diversification model. Consistent with our proposal of selection on loci of varying effect size and ecological significance, selection coefficients for Optix-bound loci with strong signals of selection were generally 4- to 10-fold lower than observed at the optix locus (Fig. 5A). Similarly, our data support the view that adaptive loci that separate morphs through the process of conditional differentiation will display signatures of genomic differentiation significantly elevated above background. In our analysis, we found that Fst at 17 of 59 Optix-bound loci with strong signals of selection was at or above the 97.5th percentile (the third SD) and often much greater (Fig. 5B). Ultimately, however, additional studies of developmental function and gene flow will be necessary to rigorously test our model of adaptive diversification of the Radiate morphology.

(A) Plot shows the estimated selection coefficients derived from alpha produced by SweepFinder2; outlier from the dome/wash locus is not shown (s = 0.082). Red bar indicates the largest selection coefficient in the optix locus. (B) Evidence of moderately strong genomic differentiation at Optix-bound loci provides support for a model incorporating conditional differentiation. Orange arrowheads highlight Optix-bound loci with Fst greater than 0.04.

In this study, we show how signatures of adaptation can manifest across a gene network. To what extent might future studies expect to uncover additional genetic variation underlying trait adaptation? The mode of multigenic evolution will partly determine the propensity for both additional genetic variation and conditional differentiation. Models of classic polygenic adaptation suggest that evolution from standing genetic variation at many independent loci is a common feature of multigenic adaptive processes (37). Adaptive alleles will often be difficult to detect for classic polygenic adaptation, but none are likely to be hidden from genetic studies of trait architecture. Multiple-step adaptation, such as the proposed two-step model for Heliconius wing pattern evolution (13, 20) supported here, diverges from classic polygenic models by implicating sequential selection at multiple loci over time and is thus less limited to only ancestral variants. That is, in multistep processes, novel variants that further modify a trait might undergo a classic hard sweep, and the multigenic trait architecture would consist of both novel and ancestral alleles. In either scenario, dependency of some alleles on another locus of large effect will likely produce an effect similar to our findings here.

The ability to detect multiple loci of adaptation will also depend on the biological context of a study system. Hard sweeps are often detected by CLR methods, while soft sweeps and minor frequency shifts proposed in some polygenic models can be more difficult to detect (38, 39). Soft sweeps on rare variants, such as deleterious alleles or variants that arose just preceding the adaptive event, will often appear similar to hard sweeps (40) and can be detected with CLR methods. Multistep adaptation along a hybrid zone, as proposed here, will likely favor soft sweeps on rare variants if the subsequent selection occurs early in the diversification process. In this scenario, the initial adaptation will create a founder-like effect as the populations split and neutral variants are slowly reintroduced by gene flow. Population size variation, such as seasonal fluctuation in population size, will also increase the hardness of a sweep (39). Where adaptation occurs from older, neutral polymorphisms in response to an environmental shift, alternative methods of detecting selective sweeps may be necessary (38). Subtle shifts in allele frequencies at multiple loci is the most problematic scenario for detecting multigenic adaptation, although this is only expected when mutation rates are extremely high or the loci under selection are highly redundant with one another (41). For taxa where adaptive introgression is likely, the ability to detect introgressed sweeps will generally fall somewhere between hard and soft selective sweeps, depending on the age of the adaptive allele in the source population, the migration rate, and the origin of the new allele. In sum, tests for selection more suited to partial sweeps from neutral variation may identify additional loci associated with diversification in Heliconius butterflies and other taxa.

Ultimately, our multigenic model of adaptive diversification in Heliconius butterflies provides some resolution to the disparity between a few QTLs of large effect and the multigenic trait architecture often seen in GWAS. QTL studies from a few source individuals and scans for genomic outliers separating phenotypes will favor a few loci of large effect when additional trait-associated variants are functionally dependent on a single gene. Understanding the molecular and developmental mechanisms of adaptation can, however, bring hidden, conditional loci of adaptation to light. Thus, more detailed analysis of the mechanisms of large-effect loci will be necessary to develop a complete theory for the processes of adaptation and diversification. Future studies incorporating many more individuals will be important for understanding the complex genetic architecture of wing polymorphisms in Heliconius. Our findings, however, show that a few functional assays can substitute for hundreds or thousands of genomic samples to identify adaptive network components (42).

Genome-wide targets of Optix binding were determined using chromatin immunoprecipitation sequencing (ChIP-seq) for the Optix protein, as previously described (17). Forewing and hindwing tissue from four to six Radiate H. erato individuals of mixed sex at 3 days after pupation were used to perform the ChIP assay. Samples were taken from a laboratory colony of H. erato derived from Ecuadorian stock and kept pure for the Radiate phenotype. Samples were dissected in phosphate-buffered saline, fixed for 7 min with fresh formaldehyde, and flash-frozen on dry ice. Samples were then combined by tissue for two replicates of both forewing and hindwing assays. Chromatin from dounced and lysed samples was sheared to approximately 250 base pairs (bp) using a Bioruptor, and IP was performed overnight with a homemade Heliconius-derived Optix antibody. Input samples were taken before adding the antibody as a control. Library preparation was performed using the NEBNext Ultra II DNA library preparation kit, and both input and control libraries were sequenced on a NextSeq 500.

ChIP-seq and input control libraries were aligned to the Radiate H. erato lativitta genome assembly (43) using Bowtie 2 (44). Nonuniquely aligning reads were removed using a custom script, and data were deduplicated using picard tools. Peak calling was performed with MACS2 (45) on the paired BAM file using default settings, a genome size estimate of 3.6 108, and the input sequencing data as a control. Peak calls from forewing and hindwing samples showed a fivefold median increase over input, and 95% of ChIP peaks overlapped previously annotated sites of accessible chromatin from ATAC-seq assays of the same developmental stage (25). Comparison of forewing and hindwing samples found that, as expected, 95.4% of peaks overlapped between wing tissues, so we generated a single, high-quality ChIP peak set of 5051 Optix binding sites that were used in subsequent analyses.

Hi-C libraries used to detect Optix binding site interactions were generated using the in situ Hi-C protocol from Rao et al. (46) with minor modifications as previously described (17). Wing tissues from forewing and hindwing Radiate H. erato butterflies were prepared as described for the ChIP-seq assays. Four to five mixed-sex individuals were combined for library preparation, wing tissue was briefly dounced, and nuclei were permeabilized using 0.1% SDS. Samples were centrifuged after ligation to remove any fragments not contained within permeabilized nuclei before reverse cross-linking, and an additional step was included to reduce fragments with unligated biotin in the final libraries. Samples were sheared on a Covaris S2 sonicator, and size was selected with 1.2 AMPure beads before library preparation. Sequencing libraries were prepared with the NEBNext Ultra II DNA library preparation kit. Samples were sequenced on a NextSeq 500.

Hi-C data alignment and analysis were performed as previously described: Hi-C libraries were aligned to the H. erato lativitta genome assembly using Juicer (47). Matching our ChIP-seq analysis, alignments from all replicates were then merged to produce a final merged_nodups.txt file containing all Hi-C fragments for subsequent analyses.

To link Optix binding sites to gene TSSs, we used a two-component pipeline. All TSS-proximal ChIP-seq peaks of less than 3 kb from a potential target (generally promoter peaks) were assigned to the proximal gene TSS. We then used the hicContactCaller pipeline from Ray et al. (48) to determine the loci that interact significantly at distances greater than 3 kb compared to an empirical background model. This method calculates the observed number of reads connecting 3-kb windows around an Optix binding site (bait) to TSSs within a predesignated distance (300 kb, prey window). An empirical expected value is determined from the local Hi-C alignments, and a Fishers exact test is calculated using observed and expected read counts connecting the bait and prey loci. Interaction between the bait and prey loci were considered significant for P values of less than 0.05, as this threshold was found to be well below the 10% false discovery rate threshold in the previous study (48).

SNP calling for H. erato samples was performed as follows: Eighteen whole genome resequencing samples from three geographically adjacent H. erato Radiate populations (Radiate metapopulation: H. erato lativitta, H. erato etylus, and H. erato emma) and 22 samples from three geographically adjacent H. erato Postman populations (Postman metapopulation: H. erato favorinus, H. erato cyrbia, and H. erato notabilis) (3) were realigned to the Radiate H. erato lativitta genome assembly (43) to produce gVCF (genomic variant call format) files using GATK HaplotypeCaller with default settings (49). Populations were categorized as either Radiate or Postman, consistent with previous analyses (3). Samples included all Radiate and Postman individuals collected along the Andean hybrid zone region; Radiate and Postman individuals from geographically distant populations, such as H. erato demophoon in Panama, were excluded. SNPs were filtered using VariantFiltration with the filter MQRankSum < -12.5 || FS > 60.0 || MQ < 20.0 and called using GenotypeGVCFs. The VCF file was then additionally filtered to include only biallelic SNPs using VCFtools (50).

SweepFinder2 (51) was used to detect signatures of selective sweeps in the Radiate H. erato metapopulation. Allele counts for all biallelic Radiate sample SNPs were generated using VCFtools. SNPs were polarized using H. erato phyllis [outgroup for East Andean Radiate and Postman metapopulations (3)] whole-genome sequencing data aligned to the H. erato lativitta genome assembly (3). The ancestral allele was marked using the VCFtools fill-aa script. A custom script was then used to convert VCFtools allele counts output to the SweepFinder2 input format. SweepFinder2 was run using default settings and set to test SNPs every 2000 bp (-sg 2000).

To test for the increased selection on all Optix binding sites, the highest CLR values from the SweepFinder2 output within 2000 bp of Optix ChIP peaks were determined using bedtools (52). To prepare a control dataset, we randomly selected the same number of unbound peaks from H. erato lativitta ATAC-seq data using shuf and determined the highest CLR value within 2000 bp. This random sample was performed 10 times, then all samples were ranked from lowest to highest, and the values were averaged for each rank position to estimate the random expected value of the same number of CREs sampled from the CRE distribution in the genome. A Kolmogorov-Smirnov test was used to test for the significant difference between the expected and Optix-bound CRE distributions. The top 500 data points for each category were plotted to increase figure resolution.

To identify putatively adaptive Optix-bound loci, we designated the top 0.5% of all CLR values, equal to or greater than 63, as sites under with a strong signal of selection. We then selected all Optix-bound loci with a CLR value at or above 63 as our initial dataset. These were predominantly CRE loci but did include one gene that showed a significant selection in the gene body and was bound by Optix at the promoter. Because some highly repetitive regions show very high CLR values and were likely regions of new repeats found only in the Radiate clade, we manually curated selected loci to discard any sites where a CLR window overlapped repetitive sequences. The three major color pattern loci identified in scans of genomic differentiation were excluded from all tests for the selection on Optix-bound loci to preclude evidence of selection on the optix locus and other known loci of large effect.

To test for evidence of three-dimensional evolution associated with selection on Optix binding sites, we combined our Hi-C data with 12 RNA-seq datasets from wing tissue at 3 days after pupation (25). RNA-seq samples were collected from laboratory colonies of a Radiate morph (H. erato lativitta) and a Postman morph (H. erato petiverana). To reduce the impact of nonadaptive evolution and nonevolving loci on our results, we limited our analysis to the loci with evidence of strong selection and differentially expressed genes between Radiate and Postman phenotypes. Thus, adaptive hubs were characterized by two requirements: (i) an Optix-bound hub center meeting our definition of a strong signal of selection and (ii) Hi-Cbased evidence of physical interaction with two or more hub gene TSSs that were differentially expressed between Radiate and Postman samples. All CLR values were used to determine the genome-wide distribution of CLR values, while all TSS and adaptive hub gene loci were characterized by the highest CLR value within 2 kb, as described above. Hub centers with strong signals of selection were excluded from our analysis of selection at hub gene loci except for the few cases where two loci displaying strong signatures of selection interacted, in which case, the hub center was excluded but the interacting locus was included. Tests for significance between adaptive hub gene CLR values and control datasets were performed with a Mann-Whitney U test.

Adaptive hub genes and genes at loci with strong signals of selection were annotated using Lepbase and FlyBase. For all genes with characterized proteins or which showed some similarity to characterized proteins, gene function was manually curated. Gene annotations were categorized as pigmentation associated given (i) evidence of a known effect on pigmentation or color patterning, (ii) the gene was annotated as a regulator of known color-patterning genes in Lepidoptera (e.g., regulation of Wnt signaling), or (iii) the gene had known effects on wing morphology in Drosophila. Gene annotations were categorized as signaling, given evidence of an important role in major signaling pathways and lacking evidence of a functional role in pigmentation. All other genes were categorized as other. Detailed gene annotations are available in the Supplementary Materials.

We calculated Fst and dxy/pi to determine the extent to which loci with strong signals of selection may associate with differentiation between the Radiate and Postman metapopulations. Sliding window Fst analysis between the Radiate and Postman metapopulation samples was calculated for 20-kb intervals with 10-kb steps using VCFtools. dxy and pi were calculated for the same intervals and step size using the Genomics-General Python library (53). Statistical tests for significant deviation from the genome-wide distribution of both statistics were performed using Mann-Whitney U tests.

In addition to detecting selective sweeps, SweepFinder2 can be used to estimate selection coefficients (23, 54). To do this, we used the formula s = (r*ln(2N)) / a to estimate selection coefficients for loci with strong signals of selection. We used the previously calculated average recombination rate (r) of 1.343 107 and estimated the Radiate metapopulation size (N) at 10M or roughly twice the size of the metapopulation effective population size (23). Alpha was taken for each locus from the SweepFinder2 output. We verified our parameters by comparing our resulting selection coefficient at optix (0.0605) with a previously calculated coefficient using the same method (0.0595).

All animals were reared in accordance with institutional guidelines.

L. Livraghi, J. J. Hanly, L. S. Loh, A. Ren, I. A. Warren, C. Concha, C. Wright, J. M. Walker, J. Foley, H. Arenas-Castro, L. R. Brenes, A. Martin, W. O. McMillan, C. D. Jiggins, The gene cortex controls scale colour identity in Heliconius. bioRxiv:2020.05.26.116533 (2020).

Acknowledgments: We thank the Cornell University Insect Collection for use of the specimens to produce butterfly images. We thank K. van der Burg, L. Campagna, V. Lewis, and two anonymous reviewers for helpful comments on the manuscript. Funding: J.J.L. was supported by NASA 17-EXO-17-2-0112, NSF DEB-1546049, and NSF IOS-1656514. S.M.V.B. was supported by NSF EPSCoR RII Track-2 FEC (OIA 1736026) and, in part, by the National Institutes of Health, NIGMS COBRE Phase 2 Award, Center for Neuroplasticity at the University of Puerto Rico (grant no. 1P20GM103642). S.M.V.B. and R.P. acknowledge support from the Puerto Rico Science, Technology & Research Trust catalyzer award (grant no. 2020-00142) and NSF IOS-1656389. C.G.D. acknowledges support from the National Institutes of Health Common Fund 4D Nucleome Program (grant U01HL129958). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Author contributions: J.J.L. conceived and designed the study. J.J.L. and S.M.V.B. produced and analyzed data. C.G.D., R.D.R., and R.P. provided materials and resources. J.J.L. and S.M.V.B. interpreted the data, and all authors wrote the manuscript. Competing interests: The authors declare that they have no competing interests. Data and materials availability: ChIP-seq, Hi-C, ATAC-seq, and RNA-seq data used in this study are available at NCBI-GEO GSE123700, GSE123701, GSE123703, GSE109889, and GSE111022. Whole-genome resequencing data are available at SRA SAMN05224096-SAMN05224211. All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. Additional data related to this paper may be requested from the authors.

See the rest here:
Many functionally connected loci foster adaptive diversification along a neotropical hybrid zone - Science Advances

Predictive Genetic Testing and Consumer/Wellness Genomics Market set to record exponential growth by 2025-end – The Daily Chronicle

Predictive Genetic Testing and Consumer/Wellness Genomics Market: Snapshot

Genetic testing comprises examination of ones DNA. The term DNA refers to the chemical database that is responsible for conveying the instructions for functions that need to be performed by the body. Genetic testing is capable of revealing changes or mutations in the genes of living beings, which might result in any kind of disease or illness in the body.

Get Exclusive PDF Sample Copy Of This Report:https://www.tmrresearch.com/sample/sample?flag=B&rep_id=1274

Predictive genetic testingrefers to the utilization of genetic testing methods in an asymptomatic individual to make a prediction about risk of contacting particular disease in future. These tests are regarded as representation of emerging class of medical tests, which differ in fundamental ways from the usual diagnostic tests.

The global predictive genetic testing and consumer/wellness genomics marketis likely to gather momentum owing to the benefits offered by predictive genetic testing.

The benefits of predictive genetic testing are

The global predictive genetic testing and consumer/wellness genomics marketis influenced by reducing cost of genetic sequencing and technological advancement in the field of genetics. North America is expected to emerge as a prominent region for the global predictive genetic testing and consumer/wellness genomics market in years to come due to high adoption rates of latest technologies in all fields.

Over centauries human DNA has undergone tremendous alteration due to evolutionary and lifestyle changes. They have led to both, advantages and disadvantages over the years. Some have given the mankind a deserving edge over other creatures while the others have led to disorders and diseases. Predictive genetic testing and consumer/wellness genomics market thrives on the growing demand for understanding the lineage of a certain gene pool to identify disorders that could manifest in the later or early stage of a human life. The surging demand for understanding the family history or studying the nature of certain diseases has given the global market for predictive genetic testing and consumer/wellness genomics market adequate fodder for growth in the past few years.

This new class of medical tests are aimed at reducing the risk of morbidity and mortality amongst consumers. The thorough surveillance and screening of a certain gene pool can allow an individual to avoid conditions that disrupt normal existence through preventive measures. The clinical utility of these tests remains unassessed. Therefore, increasing research and development by pharmaceutical companies to develop new drugs by understanding diseases and disorders is expected to favor market growth.

Unlike conventional diagnostic testing, predictive genetic testing identifies the risk associated with potential conditions. In certain cases it is also capable of stating when the disease may appear and the how severe will it be. Thus, this form of testing is expected to allow consumers to take up wellness measurements well in time to lead a life of normalcy, characterized by good health.

Buy This Report @https://www.tmrresearch.com/checkout?rep_id=1274<ype=S

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Overview

Predictive genetic testing are used to identify gene mutations pertaining to the disorders that surface at a considerably later stage in life after birth. These tests are particularly beneficial for people from a family with a history of genetic disorder, although they themselves show no symptoms of the disorder at the time of testing. Genetic testing promises to revolutionize the healthcare sector, providing crucial diagnostic details related to diverse verticals such as heart disease, autism, and cancer. As the healthcare sector touches new peaks, the global predictive genetic testing and consumer/wellness genomics market is projected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

This report on the global market for predictive genetic testing and consumer/wellness genomics analyzes all the important factors that may influence the demand in the near future and forecasts the condition of the market until 2025. It has been created using proven research methodologies such as SWOT analysis and Porters five forces. One of the key aspect of the report is the section on company profiles, wherein several leading players have been estimated for their market share and analyzed for their geographical presence, product portfolio, and recent strategic developments such as mergers, acquisitions, and collaborations.

The global predictive genetic testing and consumer/wellness genomics market, on the basis of test type, can be segmented into predictive testing, consumer genomics, and wellness genetics. The segment of predictive testing can be sub-segmented into genetic susceptibility test, predictive diagnostics, and population screening programs, whereas the segment of wellness genetics can be further divided into nutria genetics, skin and metabolism genetics, and others.

By application, the market can be segmented into breast and ovarian cancer screening, cardiovascular screening, diabetic screening and monitoring, colon cancer screening, Parkinsons or Alzheimers disease, urologic screening or prostate cancer screening, orthopedic and musculoskeletal screening, and other cancer screening. Geographically, the report studies the opportunities available in regions such as Asia Pacific, Europe, North America, and the Middle East and Africa.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Trends and Opportunities

Increasing number of novel partnership models, rapidly decreasing cost of genetic sequencing, and introduction of fragmented point-solutions across the genomics value chain as well as technological advancements in cloud computing and data integration are some of the key factors driving the market. On the other hand, the absence of well-defined regulatory framework, low adoption rate, and ethical concerns regarding the implementation, are expected to hinder the growth rate during the forecast period. Each of these factors have been analyzed in the report and their respective impacts have been anticipated.

Currently, the segment of predictive genetic cardiovascular screening accounts for the maximum demand, and increased investments in the field is expected to maintain it as most lucrative segment. On the other hand, more than 70 companies are currently engaged in nutrigenomics, which is expected to further expand the market.

Global Predictive Genetic Testing and Consumer/Wellness Genomics Market: Regional Outlook

Owing to robust healthcare infrastructure, prevalence of cardiovascular diseases, and high adoptability rate of new technology makes North America the most lucrative region, with most of the demand coming from the country of the U.S. and Canada. Several U.S. companies hold patents, which further extends the outreach of the market in the region of North America.

Companies mentioned in the research report

23andMe, Inc, BGI, Genesis Genetics, Illumina, Inc, Myriad Genetics, Inc, Pathway Genomics, Color Genomics Inc., and ARUP Laboratories are some of the key companies currently operating in global predictive genetic testing and consumer/wellness genomics market. Various forms of strategic partnerships with operating company and smaller vendors with novel ideas helps these leading players maintain their position in the market.

To know more about the table of contents, you can click @https://www.tmrresearch.com/sample/sample?flag=T&rep_id=1274

About TMR Research

TMR Research is a premier provider of customized market research and consulting services to busi-ness entities keen on succeeding in todays supercharged economic climate. Armed with an experi-enced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Read this article:
Predictive Genetic Testing and Consumer/Wellness Genomics Market set to record exponential growth by 2025-end - The Daily Chronicle

Genetic analysis finds link between obesity-related genes and rheumatoid arthritis – News-Medical.Net

Reviewed by Emily Henderson, B.Sc.Sep 23 2020

An analysis of genetic data collected from more than 850,000 individuals of European ancestry has found a link between obesity-related genes and rheumatoid arthritis.

In the Arthritis & Rheumatology analysis, investigators found an increased risk of rheumatoid arthritis when body mass index was predicted to be high based on an individual's genetics. This was observed for both men and women.

These results highlight an important role of obesity in the pathological development of rheumatoid arthritis, as well as provide a potential actionable preventive strategy. Future studies are needed to understand the biological mechanisms underlying such a link, and to understand how obesity may causally influence rheumatoid arthritis prognosis."

Xia Jiang, PhD, Senior Author, Karolinska Institute, Sweden

Source:

Journal reference:

Tang, B., et al. (2020) Obesityrelated traits and the development of rheumatoid arthritis evidence from genetic data. Arthritis & Rheumatology. doi.org/10.1002/art.41517.

Visit link:
Genetic analysis finds link between obesity-related genes and rheumatoid arthritis - News-Medical.Net